Omega Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Omega Therapeutics's balance sheet done over the years? Its assets were worth $204,366,000 last year, which is more than in the previous period. 72% of Omega Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $146,350,000, which means an increase by 266% compared compared to last year.

Debt to Assets

Omega Therapeutics, Inc. (NASDAQ:OMGA): Debt to assets
2019 6120000 42.03M 686.91%
2020 28083000 92.71M 330.13%
2021 233333000 32.70M 14.02%
2022 145998000 40.02M 27.42%
2023 204366000 146.35M 71.61%

OMGA Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
68.44M70.61M186.48M22.95M2.27M
Short term investments
4.98M54.06M38.84M00
Net receivables
6.98M1.79M521K193K5K
Inventory
303K41.15M-264K00
Other current assets
9.16M11.11M3.70M859K375K
Total current assets
89.88M124.67M229.28M24.00M2.65M
Non-current assets:
Property, Plant and Equipment
114.04M7.86M3.60M3.48M2.83M
Goodwill
00000
Intangible assets
00000
Long term investments
0341K341K341K341K
Other non-current assets
435K13.11M101K257K292K
Total non-current assets
114.48M21.32M4.04M4.08M3.46M
Total assets
204.36M145.99M233.33M28.08M6.12M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
-6.51M003.27M0
Short term debt
26.6M4.85M03M0
Total current liabilities
26.80M21.96M11.98M7.69M2.22M
Non-current liabilities:
Long term debt
113.12M17.72M19.86M8.73M11.89M
Deferred tax
00000
Other non-current liabilities
6.41M340K853K76.28M27.92M
Total non-current liabilities
119.54M18.06M20.72M85.01M39.81M
Total liabilities
146.35M40.02M32.70M92.71M42.03M
Data sourceData sourceData source